Sanofi Stock News

Global Pericarditis Drugs Market - Snapshot Pericarditis refers to a pericardial inflammation. The condition is basically a inflammation that develops surrounding the heart''s lining, resulting in chest discomfort and fluid buildup around the pericardial effusion. This might be due to a

The new study on the Global Small Molecule Prefilled Syringes Market 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Small Molecule Prefilled Syringes industry. Because of the in-depth overview of the

Conor Hale / FierceBiotech : France-based Owkin, which helps medical researchers build and train AI models, raises $180M from pharmaceuticals company Sanofi Artificial intelligence developer Owkin scored a major collaboration with Sanofi to help bring its digital clinical research platform to bear

Sanofi (OTCMKTS:SNYNF) saw a significant growth in short interest during the month of October. As of October 29th, there was short interest totalling 463,200 shares, a growth of 28.1% from the October 14th total of 361,700 shares. Based on an average trading volume of 62,100 shares, the days-to-cover ratio is presently 7.5 days. Separately, SVB []

Here are three COVID-19 stock ideas: a vaccine biotech, a big pharma stock, and an investment in a reopening.

Sanofi (NASDAQ:SNY) and Prometheus Biosciences (NASDAQ:RXDX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation. Institutional and Insider Ownership 8.0% of Sanofi shares are owned by institutional investors. Comparatively, 61.2% of Prometheus []

Owkin is on a mission to improve patients lives by using its platform to discover the right treatment for every patient.

Antiallergics drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6.90% in the above mentioned forecast period. The Antiallergics

Europe Pharmaceutical Market: Overview The Europe pharmaceutical market has been anticipated to grow at a significant speed in the forthcoming years. This market has been driven by the rising rate of healthcare expenditure, the emergence of biosimilars and biologics, and increasing

Data Bridge Market research released a new market study on Human Papillomavirus Vaccine with 100+ market data Tables, Pie Chart, Graphs & Figures spread through Pages and easy to understand detailed analysis In Human Papillomavirus Vaccine research report also

Allergic Rhinitis Market report considers the latest upgrades while assessing the development of leading market players. This global market report is comprehensive and opens a door of worldwide market for the products. The report gives helpful insights which assist while

DUBLIN, Nov. 18, 2021 /PRNewswire/ -- The "Global Auto Injector Market Outlook 2030" report has been added to ResearchAndMarkets.com''s offering. The market is estimated to garner a revenue of close to USD 11350 Million by the end of 2030, up from a revenue of about USD 3120 Million in the

Fulton Bank N.A. purchased a new stake in shares of Sanofi (NASDAQ:SNY) in the third quarter, according to its most recent 13F filing with the SEC. The fund purchased 7,493 shares of the companys stock, valued at approximately $361,000. Several other institutional investors and hedge funds have also recently added to or reduced their stakes []

Could these top biotech stocks be worth investing in for the long term?

Sanofi invests $180 million equity in Owkins artificial intelligence and federated learning to advance oncology The post Sanofi invests $180 million equity in Owkins artificial intelligence and federated learning to advance oncology pipeline first appeared on IT Business Net .